INTRODUCTION
Arterial blood gases are essential in the management of critically ill patients. Current methods of blood gas analysis require arterial blood sampling, which can only be done intermittently, have a significant turnaround time, expose the health-care professionals to the patient's blood, and results in iatrogenic blood loss. The Partrend 7 system (Diametrics Medical, High Wycombe, UK) uses a multiparameter fiber optic sensor to provide continuous measurement of pH, PCO 2 , and PO 2 and calculated values for oxygen saturation, bicarbonate, and base excess. The Paratrend 7 system consists of a monitor, patient data module, and multiparameter sensor. The system allows for continuous blood gas measurement with trend analysis eliminating sampling errors and delays. It also reduces the health-care provider's exposure to blood and decreases the patient's iatrogenic blood loss.
INTRODUCTION:
The ability to measure postmembrane arterial blood gases is essential in the management of critically ill neonates treated with extracorporeal membrane oxygenation ( ECMO ). A new technology using, the Paratrend 7 system ( Diametrics Medical, High Wycombe, UK ) allows for continuous measurement of pH, PCO 2 and PO 2 , and calculates oxygen saturation, bicarbonate, and base excess.
OBJECTIVE:
To evaluate and compare the results of continuous blood gas measurement using the Paratrend 7 system with a standard system of blood gas analysis in our intensive care unit.
DESIGN:
Prospective, controlled, interventional study.
SETTING:
The neonatal intensive care unit of a tertiary referral center.
PATIENTS:
Neonates who required extracorporeal life support and were expected to have frequent postmembrane arterial blood sampling during the testing period.
RESEARCH DESIGN AND METHOD:
To enable Paratrend 7 sensor access to the ECMO circuit, the postmembrane access port extension set that is routinely used for blood drawn for blood gas analysis was used. The study began with the insertion of the Paratrend 7 sensor. Subjects remained on the study until the ECMO was discontinued and / or frequent blood gases were no longer needed. The blood gas results from the Paratrend 7 system were not used in clinical management of the patient.
BLOOD GAS MEASUREMENT:
During the study period, with each blood sample drawn for laboratory analysis, a printout from the Paratrend 7 monitor was recorded for comparison.
RESULTS:
A total of 242 pairs of blood gas samples were collected from 10 neonates. The mean bias / precision for pH was À 0.02 / 0.04; for PO 2 68.35 / 93.44 mm Hg; and for PCO 2 1.75 / 4.23 mm Hg. The correlation ( r value ) between the sensor reading and the blood gases were 0.89 for pH, 0.96 for PO 2 , and 0.73 for PCO 2 ( Table 1 ) .
CONCLUSION:
The blood gases compared in the two methods had a strong correlation for pH, PCO 2 and PO 2 . Results of this study indicate that this technology provides an accurate means of monitoring continuous blood gas parameters in neonatal ECMO patients. Use of the Paratrend 7 should allow reduced health -care provider exposure to blood and decreased patient iatrogenic blood loss. Original Article
Journal of Perinatology
Continuous blood gas monitoring has been previously evaluated in adults, pediatric, and neonatal patients. 1 -7 The Paratrend sensor typically is threaded within an arterial catheter to the point where it extends 1.5 to 2.0 cm beyond the tip of the catheter and comes in sizes to fit within as small as a 3.7 French catheter. This study reports the results of a clinical evaluation of the Paratrend 7 system measuring postmembrane blood gases in neonatal ECMO patients. To access the extracorporeal membrane oxygenation (ECMO) circuit the multiparameter sensor was inserted using the postmembrane access port extension set.
METHODS
This study was approved by the Institutional Review Board (IRB) at Children's National Medical Center. Informed consent was obtained for all neonates enrolled into the study. The study criteria specified that the neonates were on ECMO, and required frequent postmembrane blood gas measurements during the study period.
The Paratrend 7 sensor is a fiber optic sensor with three sensing elements for monitoring pH, PCO 2 , and PO 2 plus a thermocouple for measuring temperature. The Paratrend 7 sensor is 30 cm long with a diameter of less than 0.5 mm, which provides a dead space of about 6/10,000 of a milliliter. A Y connector on the sensor allows simultaneous continuous blood pressure monitoring and enables intermittent withdrawal of blood samples and infusions.
The sensors were calibrated according to the manufacturer's instructions using the supplied precision gases. Then the calibrated sensors were inserted into the postmembrane access port extension set. The study and the data collection began with the insertion of the Paratrend 7 sensor. Subjects remained on the study until the ECMO support was discontinued and/or frequent blood gases were no longer needed. Although approved for use in neonates, for purpose of this study the Paratrend was treated as a research device, therefore the displayed data were not used in clinical management of the patient.
Blood Gas Measurements
During the study period, postmembrane blood gases were drawn only when clinically indicated. With each blood sample drawn for laboratory analysis, a printout from Paratrend 7 monitor was recorded for comparison. The blood was analyzed using an i-Stat portable clinical analyzer (i-Stat Corporation, Princeton, NJ).
Statistics
The blood gas values obtained from the i-Stat blood gas analyzer and the printouts from the Paratrend 7 monitor were compared by mean bias and precision as described. 8 Bias is the mean of the difference between the standard method of measurement (i-Stat values) and the new method (Paratrend 7). Precision is the standard deviation of these differences, an indicator of intersample reproducibility. In addition, correlation coefficient values were calculated.
RESULTS
Data from 10 neonatal ECMO patients were analyzed for this study. All were receiving extracorporeal life support at the time of placement of the sensor. No changes in the circuit blood pressure waveform were noted after the sensor was inserted into the postmembrane access port set, nor was any ECMO circuit malfunction noted because of the device.
Once measurements were initiated, the sensors remained in place and functioning until the ECMO was no longer needed. A total of 242 paired blood gases were collected. The mean bias/precision for pH was À0.02/0.04; for PO 2 68.35/93.44 mm Hg; and for PCO 2 1.75/ 4.23 mm Hg (Figure 1 ). The correlation (r value) between the sensor reading and the blood gases were pH 0.86, PO 2 0.96, and PCO 2 0.73 (Table 1) .
DISCUSSION
Results of this study indicate that the Paratrend 7 system provides an accurate means of monitoring continuous blood gas parameters in neonatal ECMO patients. The system allows for continuous blood gas measurement eliminating sampling errors and delays. The data show that the Paratrend 7 measurements of pH, PO 2 , and PCO 2 are strongly correlated with conventional intermittent blood gas data. We did not make any conclusion about the displayed values for bicarbonate, base excess, or oxygen saturation, as these parameters are not directly measured by either device, rather calculated.
Although this study did not analyze the potential for blood drawing, it is only logical that, in patients who require frequent blood gas analysis a day, eliminating most of them would significantly decrease the amount of blood drawn. Perhaps, over the life of the sensor this may reduce the need for transfusion secondary to iatrogenic blood loss. 9 It also allows reduced health-care provider exposure to blood.
A study of cost analysis was not done as part of our protocol, although it is logical that the use of this technology could significantly impact patient charges. This is an especially important consideration in the managed care system.
Our data suggest a potential role for continuous postmembrane blood gas monitoring in management of critically ill neonates on extracorporeal life support. This would allow maximizing the clinicians' ability to immediately recognize changes in physiologic status, such as membrane oxygenator dysfunction, therefore allowing timely intervention. Should this level of monitoring become standard, we would expect an improvement in the care of critically ill neonates on ECMO in the neonatal intensive care unit. 
